Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Provincial Health Services Authority currently has 3 pending office actions within its company patent portfolio. These actions are located in the Biotechnology & Pharmaceuticals technology area. The prosecution of these matters involves 3 distinct examiners and 2 distinct art units. This distribution suggests that the portfolio covers several different technical sub-categories within the biotechnology field.
LYONS, MICHAEL A is the busiest examiner for this company, with 1 pending office action. Although LYONS, MICHAEL A is the busiest, the 3 distinct examiners across the portfolio mean that every pending application is being reviewed by a different individual. This requires the authority to manage multiple examiner relationships simultaneously.
The 2 distinct art units indicate that the 3 pending office actions are distributed across different specialized groups at the USPTO. With only 1 pending office action assigned to the busiest examiner, no single individual dominates the prosecution of the entire portfolio. Practitioners should prepare for diverse feedback across the 3 distinct examiners currently assigned to these cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LYONS, MICHAEL A | 1 | 86.5% | +10.0% |
| BURKETT, DANIEL JOHN | 1 | 62.6% | +33.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728810 | ANALYZER SYSTEM AND METHOD FOR REAL-TIME SYNCHRONOUS DETECTION OF THE CHARACTERISTIC NEAR-INFRARED WAVELENGTH FEATURES OF OPTICALLY ACTIVE SUBSTANCES | LYONS, MICHAEL A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17641813 | DNA-PK INHIBITING COMPOUNDS | BURKETT, DANIEL JOHN | 79d overdue |
| 18728810 | ANALYZER SYSTEM AND METHOD FOR REAL-TIME SYNCHRONOUS DETECTION OF THE CHARACTERISTIC NEAR-INFRARED WAVELENGTH FEATURES OF OPTICALLY ACTIVE SUBSTANCES | LYONS, MICHAEL A | — |
| Art Unit | Apps |
|---|---|
| 2871 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18728810 | ANALYZER SYSTEM AND METHOD FOR REAL-TIME SYNCHRONOUS DETECTION OF THE CHARACTERISTIC NEAR-INFRARED WAVELENGTH FEATURES OF OPTICALLY ACTIVE SUBSTANCES | LYONS, MICHAEL A | 2871 | §102§112 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 17641813 | DNA-PK INHIBITING COMPOUNDS | BURKETT, DANIEL JOHN | 1624 | §112 | Non-Final OA | 79d overdue | Pending | Mar 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial